Royalty Report: Medical, Delivery, Device – Collection: 1862


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Delivery
  • Device

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1862

License Grant
The Company also has entered into an Assignment Agreement dated June 30, 1998, pursuant to which the Company assigned all of its rights, duties and obligations under its Osteoport® device patent license agreement; drug-injection device.
License Property
The bolt-like device is implanted in the hip or shinbone and its self-sealing rubber cap lies just below the skin.   A needle can be inserted through the skin and into the plug.  The injected fluids are then absorbed into the bloodstream through the veins in the bone marrow.

IPSCIO Record ID: 1786

License Grant
The Licensee has assigned the cannula patent to the Company; patented peel-away needle catheter placement system consists of a stainless steel needle (the cannula) through and by which a flexible catheter is inserted.

IPSCIO Record ID: 1686

License Grant
Inventors, two of whom are former officers and directors of the Licensee hereby grant and Licensees hereby accept exclusive licenses for the entire world to make, use and sell Products. Such licenses are perpetual, subject to the payment of royalties as provided herein.
License Property
'Gel Patents' shall refer to United States Patent No. 5,067,965, Bio-Oncotic Gel for Implant Protheses
'Micro Implant Patents and Patent Applications' refers to United States patent Application Serial Number 07/232,671, an Application, allowed in part and issued on November 2, l993, as Patent No. 5,258,028, United States Patent for Textured Micro Implants

'Reflux Disorders Patent Application' refers to United States Patent Application Serial Number 07/863,848, entitled Treatment of Urologic and Gastric Fluid Reflux Disorders by Injection of Micro Particles

Field of Use
Multiple patents Macroplastique(r) Implants are an injectable medical device implant designed to treat certain forms of urinary / in a minimally invasive procedure involving injection of the product material through a needle into the soft tissue at the bladder neck to act as a tissue bulking agent.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.